approved EB-2 (NIW)
Scientist
Healthcare · India · 2025-01-31
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.
Proposed Endeavor
The petitioner proposes to advance biostatistical and epidemiological methodologies to analyze large-scale health data and develop innovative diagnostic and therapeutic frameworks. Her work focuses on addressing infectious diseases, cancer, and metabolic disorders through the application of advanced statistical and computational methods to clinical trials.
Why This Petition Was Approved
The petition was approved based on the petitioner's 13 peer-reviewed journal articles and 4 abstracts which garnered 130 citations. Her participation in prestigious consortia like METRC and PREP-IT, along with expert testimony confirming her impact on medical standards for trauma care, satisfied the Dhanasar prongs.
Similar Cases
Others
Research and Development · China
WeGreened EB-2 (NIW) approved
California 94 days 2025-02-11
The petitioner proposes to conduct data analysis and medical research on disease development to improve diagnosis and treatment outcomes. Her work focuses on advancing data processing techniques, advanced modeling, simulation, and machine learning to provide actionable insights for a range of diseases.
Research Scientist
Research and Development · China
WeGreened EB-2 (NIW) approved
New Jersey 367 days 2022-04-05
The petitioner proposes to develop and apply novel statistical methodologies to more accurately evaluate healthcare data and improve treatment efficacy. Her work focuses on characterizing the mechanisms for conditions such as cancer and COVID-19 to improve global treatment strategies.
Statistician
Biotechnology · Taiwan
WeGreened EB-2 (NIW) approved
New Jersey 50 days 2025-03-09
The petitioner proposes to enhance the design and analysis of clinical trials through advanced statistical methodologies and machine learning. His work focuses on creating innovative tools that optimize clinical trial accuracy and accelerate therapeutic approvals for oncology, cardiovascular diseases, and infectious diseases. This endeavor aims to improve public health outcomes by ensuring regulatory compliance and addressing safety evaluation challenges in complex medical conditions.
Researcher
Research and Development · China
WeGreened EB-2 (NIW) approved
Massachusetts 5 days 2024-01-31
The petitioner proposes to continue improving advanced biostatistical techniques for cardiovascular disease clinical trials. This work focuses on supporting better treatment protocols, patient outcomes, and healthcare policies through the creation of robust clinical trial methodologies.
Frequently Asked Questions
A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-01-31.
Browse all casesAt a Glance
Outcome approved
Processing 28 days
EB-2 (NIW) Case Data
Scraped Case Data
Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist